51吃瓜黑料曝料

Skip to main content
Back to Top
51吃瓜黑料曝料 LogoShield

Information for:

  • Current Students
  • Alumni
  • Community
  • Faculty & Staff
  • Military

Resources

  • A-Z Index
  • Campus Maps
  • Libraries
  • Jobs & Careers
  • Portals
  • Shuttles
  • Admissions
  • Academics
  • About
  • Student Life
  • Research
  • Health
  •   Giving
Georgia CaRES
  • About
    • Overview
    • For Cancer Patients
    • For Cancer Professionals
  • Current Trials
  • Locations
    • 51吃瓜黑料曝料 Oncology
      • About
      • Principal Investigator
    • Cancer Care Delivery Research
      • About
      • Principal Investigator
    • DeKalb Medical Cancer Center
      • About
      • Principal Investigator
    • Georgia Cancer Center
      • About
      • Principal Investigator
    • Morehouse School of Medicine
      • About
      • Principal Investigator
    • Pediatric Cancer Research
    • Phoebe Cancer Center
      • About
      • Principal Investigator
    • University Cancer & Blood Center
      • About
      • Principal Investigator
  • 51吃瓜黑料曝料
  • Georgia Cancer Center
  • Clinical Trials
  • Georgia CaRES
  • Current Trials

Current Trials

MINORITY/UNDERSERVED NCI COMMUNITY ONCOLOGY RESEARCH PROGRAM

Use of a Clinical Screening Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)
Target: n/a Total: 2374

SPECIMEN COLLECTION  AUGUSTA UNIVERSITY
Early Onset Malignancies Initiative (EOMI): Molecular profiling of Breast, Prostate, Colorectal, Liver, Kidney, and Multiple Myeloma among Racially and Ethnically Diverse Populations

AUGUSTA UNIVERSITY
Patient-derived Models Tissue Procurement Protocol for the National Cancer Institute

MOLECULAR ANALYSIS FOR THERAPY CHOICE (MATCH)


Screening Target: 6452 Screening Total: 6507
Intervention Target: 1425 Intervention Total: 778

BREAST PROTOCOLS OPEN TO ENROLLMENT

AUGUSTA UNIVERSITY, ATHENS & DEKALB MEDICAL

Target: 317 Total: 221

AUGUSTA UNIVERSITY, ATHENS & DEKALB MEDICAL

Target: 1475 Total: 1113

AUGUSTA UNIVERSITY, ATHENS & DEKALB MEDICAL

ATHENS & DEKALB MEDICAL

AUGUSTA UNIVERSITY, ATHENS & DEKALB MEDICAL

ATHENS & DEKALB MEDICAL

ATHENS & DEKALB MEDICAL

ATHENS, DEKALB MEDICAL & PHOEBE CANCER CENTER

AUGUSTA UNIVERSITY, ATHENS & DEKALB MEDICAL

AUGUSTA UNIVERSITY, ATHENS & DEKALB MEDICAL

AUGUSTA UNIVERSITY, ATHENS, DEKALB MEDICAL & PHOEBE CANCER CENTER

AUGUSTA UNIVERSITY, ATHENS & DEKALB MEDICAL

AUGUSTA UNIVERSITY, ATHENS & DEKALB MEDICAL

Target: 1000 Total: 171

 

GYNECOLOGICAL PROTOCOLS OPEN TO ENROLLMENT

AUGUSTA UNIVERSITY
Target: 210 Total: 132

AUGUSTA UNIVERSITY
Target: 128 Total: 49

AUGUSTA UNIVERSITY
Target: 52 Total: 36

AUGUSTA UNIVERSITY & DEKALB MEDICAL
Target: 285 Total: 171

AUGUSTA UNIVERSITY
Target: 188 Total: 97

AUGUSTA UNIVERSITY
Target: 147 Total: 17

AUGUSTA UNIVERSITY & DEKALB MEDICAL
Target: 488 Total: 32

GYNECOLOGICAL PENDING PROTOCOLS

AUGUSTA UNIVERSITY
Target: 184 Total: 0  

GYNECOLOGICL PREVENTION PROTOCOLS OPEN TO ENROLLMENT

AUGUSTA UNIVERSITY, DEKALB MEDICAL & MOOREHOUSE
Target: 1150 Total: 1129

AUGUSTA UNIVERSITY, ATHENS & DEKALB MEDICAL
Target: 612 Total: 179

BRAIN

ATHENS
Target: 576 Total: 310

ATHENS
Target: 130 Total: 14

HEAD AND NECK PROTOCOL OPEN TO ENROLLMENT

AUGUSTA UNIVERSITY, ATHENS & DEKALB MEDICAL
Temporarily Closed to Accrual


Target: 660 Total: 204 

ADULT LEUKEMIA PENDING PROTOCOLS

AUGUSTA UNIVERSITY
 

ADULT LEUKEMIA PROTOCOLS OPEN TO ENROLLMENT

AUGUSTA UNIVERSITY, ATHENS & DEKALB MEDICAL
Target: 200 Total: 25

Temporarily Closed to Accrual

Cohort 1 Closed

 

LYMPHOMA PROTOCOLS OPEN TO ENROLLMENT

AUGUSTA UNIVERSITY

Target: 302 Total: 24

AUGUSTA UNIVERSITY

Target: 689 Total: 17

LUNG PROTOCOLS OPEN TO ENROLLMENT

AUGUSTA UNIVERSITY, ATHENS, DEKALB MEDICAL & PHOEBE CANCER CENTER
Phase II/III Biomarker-Driven Master Protocol for Second Line Therapy of Squamous Cell Lung Cancer
Target: 10000 Total: 1592

ALCHEMIST

AUGUSTA UNIVERSITY, ATHENS, DEKALB MEDICAL & PHOEBE CANCER CENTER 


Target: 8300 Total: 3046

Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC) 
Target: 450 Total: 194

A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib Versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein 
Target: 378 Total: 61


Target: 714 Total: 338

PENDING LUNG PROTOCOLS

AUGUSTA UNIVERSITY & DEKALB MEDICAL

Target: 169 Total: 0 

OPEN MELANOMA PROTOCOLS

AUGUSTA UNIVERSITY, ATHENS & DEKALB MEDICAL

Target: 300 Total: 140 

AUGUSTA UNIVERSITY, ATHENS & DEKALB MEDICAL
Temporarily Closed


Target: 400 Total: 250

GASTROINTESTINAL

ATHENS

Target: 148 Total: 39 

PREVENTION PROTOCOL OPEN TO ENROLLMENT

AUGUSTA UNIVERSITY
The Caucasian/other races cohort is closed to accrual


Target: 1000 Total: 1006 

CCDR PROTOCOLS

AUGUSTA UNIVERSITY

Target: 172 Total: 48

AUGUSTA UNIVERSITY

Target: 3960 Total: 1632

CCDR PROTOCOLS PENDING

PEDIATRIC PROTOCOLS OPEN TO ENROLLMENT (AU)


Target: 17230 Total: 16078

Target: 5872 Total: 8906 

Temporarily Closed

Target: 5437 Total: 5031

Temporarily Closed

Target: 1400 Total: 832


Target: 400 Total: 399


Target: 330 Total: 189


Target: 8100 Total: 3482  


Target: 621 Total: 198

Neuroblastoma Biology Studies
Target: 10,000 Total: 9869


 
Total: 5987


Target: 340 Total: 115
 

 

NCORP Badge 2020

University Shield

51吃瓜黑料曝料

1120 15th Street, 51吃瓜黑料曝料, GA 30912

  •   Campus Maps
  •   Campus Contacts
  • A-Z Directory
  • Degrees & Programs
  • Employment
  • Accessibility
  • Accreditation
  • Campus Safety
  • Compliance Hotline
  • Privacy Notices
  • Title IX / Sexual Misconduct
Apply Now Give Now

漏 2025 51吃瓜黑料曝料